AC Immune SA Forecast, price target & analysts
AC Immune SA Target price 2026 - Analyst rating & recommendation
AC Immune SA Classifications & Recommendation
AC Immune SA Price Target
| Target Price | $9.66 |
| Price | $2.81 |
| Potential |
243.71%
register free of charge
|
| Number of Estimates | 6 |
|
6 Analysts have issued a price target AC Immune SA 2027 .
The average AC Immune SA target price is $9.66.
This is
243.71%
register free of charge
$12.60
348.40%
register free of charge
$5.45
94.09%
register free of charge
|
|
| A rating was issued by 10 analysts: 9 Analysts recommend AC Immune SA to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the AC Immune SA stock has an average upside potential 2027 of
243.71%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 4.30 | 25.35 |
| 86.91% | 492.27% | |
| EBITDA Margin | -1,856.74% | -204.17% |
| 909.81% | 89.00% | |
| Net Margin | -1,971.16% | -203.73% |
| 957.34% | 89.66% |
6 Analysts have issued a sales forecast AC Immune SA 2026 . The average AC Immune SA sales estimate is
This results in the following potential growth metrics:
3 Analysts have issued an AC Immune SA EBITDA forecast 2026. The average AC Immune SA EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 AC Immune SA Analysts have issued a net profit forecast 2026. The average AC Immune SA net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.84 | -0.51 |
| 37.70% | 39.29% | |
| P/E | negative | |
| EV/Sales | 7.16 |
6 Analysts have issued a AC Immune SA forecast for earnings per share. The average AC Immune SA EPS is
This results in the following potential growth metrics and future valuations:
Current AC Immune SA Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| BTIG |
Locked
➜
Locked
|
Locked | Sep 23 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 20 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | May 04 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Mar 16 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Nov 04 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Sep 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 23 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 20 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
May 04 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Mar 16 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Nov 04 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Sep 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
